|
SERINC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.918300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.230500E-02 |
| Normal-vs-Stage2 |
4.197200E-01 |
| Normal-vs-Stage3 |
6.362500E-03 |
| Normal-vs-Stage4 |
2.452300E-02 |
| Stage1-vs-Stage2 |
4.833400E-01 |
| Stage1-vs-Stage3 |
2.211800E-01 |
| Stage1-vs-Stage4 |
3.882600E-01 |
| Stage2-vs-Stage3 |
1.267210E-01 |
| Stage2-vs-Stage4 |
2.249800E-01 |
| Stage3-vs-Stage4 |
9.676200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.256300E-02 |
| Normal-vs-AfricanAmerican |
6.278000E-01 |
| Normal-vs-Asian |
1.495990E-01 |
| Caucasian-vs-AfricanAmerican |
2.444000E-02 |
| Caucasian-vs-Asian |
5.561000E-01 |
| AfricanAmerican-vs-Asian |
1.410030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.280700E-03 |
| Normal-vs-Female |
6.310300E-02 |
| Male-vs-Female |
3.862200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.165590E-01 |
| Normal-vs-Age(41-60Yrs) |
3.858400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.940700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.675420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.142000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.637840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.688400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.104000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.366600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.107400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.482020E-01 |
| Classical-VS-Follicular |
5.666000E-01 |
| Classical-VS-Other |
6.613800E-02 |
| Classical-VS-Normal |
1.287570E-01 |
| Tall-VS-Follicular |
2.891400E-01 |
| Tall-VS-Other |
2.092400E-01 |
| Tall-VS-Normal |
1.055750E-02 |
| Follicular-VS-Other |
1.505450E-01 |
| Follicular-VS-Normal |
8.180400E-02 |
| Other-VS-Normal |
8.042600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.564400E-02 |
| Normal-vs-N1 |
6.420900E-03 |
| N0-vs-N1 |
1.990400E-01 |
|
|
